Forgot to mention, that the SITC presentation is expected to confirm that we should be excited about the results of the Vaxinia Mast trial next year. We already know that Azer-cel results from the Ph1B trial have a very high probability of being outstanding.
After SITC we will have all the information needed to make good decisions about our holdings in IMU. The roadmap will be very clear.
Dont be fooled by the current shareprice.
IMU Price at posting:
4.2¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)